HFEPX · Eval paper review
Kamalakkannan Ravi, Mengshu Nie, Annapurna Poduri, Cong Liu
Published
Nov 4, 2026
Citations
0
Trust level
Moderate
Usefulness score
65/100 (Medium)
Extraction confidence
70% (Moderate)
Derived from extracted protocol signals and abstract evidence.
Rater population
Domain Experts
Signals refreshed
Nov 4, 2026
This paper has useful evaluation signal, but protocol completeness is partial; pair it with related papers before deciding implementation strategy.
Use this for comparison and orientation, not as your only source.
Best use
Secondary protocol comparison source
Use if you need
A secondary eval reference to pair with stronger protocol papers.
What to verify
Validate the evaluation procedure and quality controls in the full paper before operational use.
Main weakness
No major weakness surfaced.
Useful as a secondary reference; validate protocol details against neighboring papers.
If you are doing eval pipeline work, start here
Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients. Many affected people discuss their results in public online health communities that clinical recontact often does not reach. We built PRISM, an agentic large-language-model pipeline that screens these posts, checks whether the variant was later reclassified, and drafts a disclaimer-bearing outreach message, in a no-contact dry run. Across 3.9 million posts from 32 communities, agent-predicted reinterpretation-relevant discussion is rare (0.288%) but concentrated in specialist genetics communities (6.30% versus 0.10% in general medical-advice communities) and growing fivefold since 2014; PRISM surfaces 123 candidate classification differences, 5 of them from an uncertain submission to pathogenic or likely pathogenic. On a held-out set of 30 real-post drafts, a clinician judged 27 factually grounded and 15 fit to send: factual accuracy is necessary but not sufficient for clinically acceptable outreach. PRISM contributes a population-scale reinterpretation-need map with code and data to be released upon publication.
These are the protocol signals we could actually recover from the available paper metadata. Use them to decide whether this paper is worth deeper reading.
Expert Verification
Directly usable for protocol triage.
"Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients."
Automatic Metrics
Includes extracted eval setup.
"Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients."
Not reported
No explicit QC controls found.
"Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients."
Not extracted
No benchmark anchors detected.
"Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients."
Accuracy
Useful for evaluation criteria comparison.
"On a held-out set of 30 real-post drafts, a clinician judged 27 factually grounded and 15 fit to send: factual accuracy is necessary but not sufficient for clinically acceptable outreach."
Domain Experts
Helpful for staffing comparability.
"Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients."
No benchmark or dataset names were extracted from the available abstract.
Genetic variants are routinely reclassified in ClinVar after a patient is tested, sometimes from uncertain to pathogenic, yet patient recontact is inconsistent, with no clear duty and responsibility diffused among labs, providers, and patients.
Based on abstract + metadata only. Check the source paper before making high-confidence protocol decisions.
Human feedback protocol is explicit
Detected: Expert Verification
Evaluation mode is explicit
Detected: Automatic Metrics
Quality control reporting appears
No calibration/adjudication/IAA control explicitly detected.
Benchmark or dataset anchors are present
No benchmark/dataset anchor extracted from abstract.
Metric reporting is present
Detected: accuracy
